Connective tissue disorder – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:24:18 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Connective tissue disorder – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 A study to evaluate the effectiveness of NAV-240 in adults with moderate-to-severe hidradenitis suppurativa https://clinicaltrials.eu/trial/a-study-to-evaluate-the-effectiveness-of-nav-240-in-adults-with-moderate-to-severe-hidradenitis-suppurativa/ Wed, 29 Apr 2026 15:09:39 +0000 https://clinicaltrials.eu/trial/a-study-to-evaluate-the-effectiveness-of-nav-240-in-adults-with-moderate-to-severe-hidradenitis-suppurativa/ This study investigates a treatment for individuals with Hidradenitis Suppurativa, a chronic skin condition that causes painful bumps, abscesses (painful, pus-filled lumps), and draining tunnels (channels under the skin that leak fluid) under the skin. The research aims to determine if the experimental drug NAV-240 is more effective than a placebo in managing this condition.

Participants in this clinical trial will be randomly assigned to receive either NAV-240 or a placebo consisting of sodium chloride. The medication will be administered through an intravenous method, which means it is delivered directly into a vein using a solution for infusion. To ensure the results are reliable, the study is double-blind, meaning neither the participants nor the researchers know which treatment is being given during the course of the study.

]]>